European Leukemia Trial Registry
Trial: EUROPE

More Details
Title Validierung eines prognostischen Modells zum Ansprechen von Niedrigrisiko-MDS mit Thrombozytopenie auf Romiplostim
Scientific Title Prospective validation of a predictive model of response to romiplostim in patients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia - the EUROPE trial.
Short Title EUROPE
Trialgroup Deutsche MDS
Type of Trial multicentric, single-group, prospective, open-label
Disease Myelodysplastic Syndrome(MDS) Low risk and intermedia I
Age >= 18 years
Status Active
Start of Recruitment 01.02.2015
Leader Platzbecker, Prof. Dr. med., Uwe
Contactperson

Administrative needs
Gloaguen, Silke
Tel: +49 (0)351 4584722
Email: silke.gloaguen@uniklinikum-dresden.de

Shortprotocol Shortprotocol
created 11.10.2016 Student Studienregister
changed 06.12.2016 Eva-Maria Ableidinger
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org